Scholar Rock Holding Corporation
Organization details
- Legal name
- Scholar Rock Holding Corporation
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SRRK
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001727196
- EIN
- 82-3750435
Board of directors
-
Akshay Vaishnaw · Director · President of R&DSince 2023
-
Amir Nashat · DirectorSince 2023
-
David Hallal · Director · Chief Executive OfficerSince 2023
-
Jay T. Backstrom · Director · CHIEF EXECUTIVE OFFICERSince 2024
-
Jeffrey S. Flier · DirectorSince 2023
-
Joshua Reed · DirectorSince 2023
-
Katie Peng · DirectorSince 2024
- Since 2023
-
Michael Gilman · DirectorSince 2023
-
Richard Brudnick · DirectorSince 2023
- Since 2023
Chief executives
Director election results
Annual meeting of June 27, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
79.9%
-
88.4%
-
90.3%
Board connections
8 of this board's directors also sit on 18 other boards. 17 are in the same sector.
-
Kalaris Therapeutics Inc. Same sectorvia David Hallal and Srinivas Akkaraju
-
Adicet Bio Inc. Same sectorvia Katie Peng
-
Agios Pharmaceuticals Inc. Same sectorvia Jay T. Backstrom
-
Alumis Inc. Same sectorvia Srinivas Akkaraju
-
Beam Therapeutics Inc. Same sectorvia Kristina Burow
-
Boundless Bio Inc. Same sectorvia Kristina Burow
-
CAMP4 Therapeutics Corporation Same sectorvia Amir Nashat
-
Disc Medicine Inc. Same sectorvia Jay T. Backstrom
-
Editas Medicine Inc. Same sectorvia Akshay Vaishnaw
-
Gossamer Bio Inc. Same sectorvia Kristina Burow
-
Hemab Therapeutics Holdings Inc. Same sectorvia Akshay Vaishnaw
-
InflaRx N.V. Same sectorvia Richard Brudnick
-
Kardigan Inc. Same sectorvia Kristina Burow
-
Mineralys Therapeutics Inc. Same sectorvia Srinivas Akkaraju
-
Neumora Therapeutics Inc. Same sectorvia Kristina Burow
- via David Hallal
-
VolitionRX Limited Same sectorvia Richard Brudnick
-
vTv Therapeutics Inc. Same sectorvia Srinivas Akkaraju
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $11,999,922
- 6 purchases by 1 insider
- Sold, last 12 months
- $19,441,551
- 38 sales by 13 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 26, 2026 | Srinivas Akkaraju Director | Open-market purchase | +48,988 | $41.59 | $2,037,411 |
| Oct 26, 2026 | Srinivas Akkaraju Director | Open-market purchase | +97,982 | $41.59 | $4,075,071 |
| Oct 23, 2026 | Srinivas Akkaraju Director | Open-market purchase | +47,000 | $41.31 | $1,941,570 |
| Oct 23, 2026 | Srinivas Akkaraju Director | Open-market purchase | +94,000 | $41.31 | $3,883,140 |
| Oct 23, 2026 | Srinivas Akkaraju Director | Open-market purchase | +500 | $41.82 | $20,910 |
| Oct 23, 2026 | Srinivas Akkaraju Director | Open-market purchase | +1,000 | $41.82 | $41,820 |
| Sep 24, 2026 | Keith Woods Officer (Chief Operating Officer) | Gift | −48,034 | — | — |
| Sep 21, 2026 | David Hallal Director, Officer (Chief Executive Officer) | Gift | −36,652 | — | — |
| Jul 1, 2026 | Kristina Burow Director | Open-market sale | −2,105 | $53.49 | $112,596 |
| Jul 1, 2026 | Jeffrey S. Flier Director | Open-market sale | −1,568 | $53.53 | $83,935 |
| Jul 1, 2026 | Michael Gilman Director | Open-market sale | −1,346 | $53.54 | $72,065 |
| Jul 1, 2026 | Katie Peng Director | Open-market sale | −2,988 | $53.56 | $160,037 |
| Jul 1, 2026 | Joshua Reed Director | Open-market sale | −2,105 | $53.50 | $112,618 |
| Jul 1, 2026 | Kristina Burow Director | Open-market sale | −948 | $54.28 | $51,457 |
| Jul 1, 2026 | Jeffrey S. Flier Director | Open-market sale | −1,470 | $54.24 | $79,733 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Scholar Rock Holding Corporation
Who is the CEO of Scholar Rock Holding Corporation?
Jay T. Backstrom is Scholar Rock Holding Corporation's CHIEF EXECUTIVE OFFICER.
How many directors are on Scholar Rock Holding Corporation's board?
Scholar Rock Holding Corporation's board has 11 directors: Akshay Vaishnaw, Amir Nashat, David Hallal, Jay T. Backstrom, Jeffrey S. Flier, Joshua Reed, Katie Peng, Kristina Burow, Michael Gilman, Richard Brudnick and 1 other.
Are Scholar Rock Holding Corporation insiders buying or selling shares?
Over the last 12 months, Scholar Rock Holding Corporation insiders bought $12.0 million of shares in 6 purchases and sold $19.4 million of shares in 38 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="scholar-rock-holding-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.